Condition: Coronary Artery Disease · Sponsor: Shiraz University of Medical Sciences
After PCI for CCS patients, single center double blind randomization will be done and patients will receive aspirin 80 mg and clopidogrel 75 mg versus 90 mg two times daily of ticagrelor, for 6 months and MACE will be followed in registry of professor Kojuri cardiology clinic
This description comes directly from the study's public registry record.
javad UOM Kojuri, MD.MS · 09171115083 · kojurij@yahoo.com
javad UOM Kojuri, MD.MS. · 09171115083 · kojurij@yahoo.com
Always discuss trial participation with your own doctor first.
| Cardiology Ward Shiraz University of Medical Sciences | Shiraz, Fars, Iran | Recruiting |
| professor Kojuroi cardiology clinic | Shiraz, Iran | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06509893